Department of Internal Medicine, New York Presbyterian Hospital - Weill Cornell, New York, NY, USA.
Sangath, Bhopal, India.
J Affect Disord. 2021 Apr 1;284:157-182. doi: 10.1016/j.jad.2021.01.092. Epub 2021 Feb 5.
Internet-based interventions show clinical effectiveness for treating anxiety disorders and depression and could make mental healthcare more affordable.
We searched databases including PubMed; EMBASE; Cochrane Central; PsychINFO; CINAHL; EconLit; and Web of Science from January 1, 2000 to August 21, 2020. Inclusion criteria were: 1) pertained to the treatment or prevention of anxiety disorders or depression; 2) evaluated the use of an internet-delivered psychological intervention; 3) recruited participants; and 4) reported costs or cost-effectiveness.
Of the 6,069 articles identified, 33 targeted anxiety (N=13) and depression (n=20) and met final inclusion criteria. All studies were from high-income countries. The control conditions and cost components included were heterogeneous. Only eight studies reported costs of developing the intervention. Of 27 studies that made a conclusion about cost-effectiveness, 81% of interventions were cost-effective. The quality of studies included was high based on a quality assessment checklist of economic evaluations, although many studies did not include definitions of cost components or differentiate between patient-side and system-level costs.
Studies varied in methodology, making conclusions about cost-effectiveness difficult. The generalizability of these results is unclear as studies were clustered in a small number of high-income countries and costs vary over time and between regions.
Internet-delivered interventions appeared to be cost-effective although control conditions and cost component reporting were variable. We propose a checklist of cost components for future cost analyses to better compare intervention costs. More research is needed to describe development costs, cost-effectiveness in low-resource settings, and cost-effectiveness of newer technologies.
基于互联网的干预措施在治疗焦虑症和抑郁症方面显示出临床效果,并且可以使精神保健更加负担得起。
我们从 2000 年 1 月 1 日至 2020 年 8 月 21 日在包括 PubMed、EMBASE、Cochrane 中央、PsychINFO、CINAHL、EconLit 和 Web of Science 在内的数据库中进行了搜索。纳入标准为:1)涉及焦虑症或抑郁症的治疗或预防;2)评估互联网提供的心理干预的使用;3)招募参与者;4)报告成本或成本效益。
在确定的 6069 篇文章中,有 33 篇针对焦虑症(N=13)和抑郁症(n=20),并符合最终纳入标准。所有研究均来自高收入国家。对照组和成本构成因素各不相同。只有八项研究报告了干预措施开发的成本。在 27 项对成本效益做出结论的研究中,81%的干预措施具有成本效益。根据经济评估质量评估清单,纳入研究的质量很高,尽管许多研究没有包括成本构成的定义或区分患者侧和系统级成本。
研究方法不同,因此难以对成本效益做出结论。由于研究集中在少数高收入国家,并且成本随时间和地区而异,因此这些结果的普遍性尚不清楚。
尽管对照组和成本构成报告存在差异,但互联网提供的干预措施似乎具有成本效益。我们建议制定成本构成清单,以进行未来的成本分析,从而更好地比较干预措施的成本。需要进一步研究以描述开发成本、在资源匮乏环境中的成本效益以及新技术的成本效益。